EP3630723
SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.5.2018EP published:
24.8.2022EP application number:
18728541.6
EPO information:
European Patent Register
Max expiry date:
17.5.2038
Title in English:
SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORSLanguage of the patent:
English
Timeline
Today
18.5.2018EP application
24.8.2022EP Publication
Owner
Name:
Janssen Pharmaceuticals, Inc.Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, US
Name:
Katholieke Universiteit LeuvenAddress:
Waaistraat 6, Bus 5105, 3000 Leuven, BE
Inventor
Name:
BONFANTI, Jean-FrançoisAddress:
92787 Issy-les-Moulineaux Cedex 9, FR
Name:
KESTELEYN, Bart, Rudolf, RomanieAddress:
2340 Beerse, BE
Name:
BARDIOT, Dorothée, Alice, Marie-EveAddress:
3001 Leuven (Heverlee), BE
Name:
MARCHAND, Arnaud, Didier, MAddress:
3001 Leuven (Heverlee), BE
Name:
COESEMANS, ErwinAddress:
2340 Beerse, BE
Name:
FORTIN, Jérôme, Michel, ClaudeAddress:
92787 Issy-les-Moulineaux Cedex 9, FR
Name:
MERCEY, Guillaume, Jean, MauriceAddress:
92787 Issy-les Moulineaux Cedex 9, FR
Name:
RABOISSON, Pierre, Jean-Marie, BernardAddress:
2340 Beerse, BE
Priority
Number:
17172237Date:
22.5.2017Country:
EP
Classification
Categories:
C07D 209/08, A61K 31/403, A61P 31/12